Webinar
The Quiet Revolution: How GLP-1 Drugs are Reshaping Beauty Standards and Cosmetic Culture
Submit the form to view the webinar recording.
Register Now
More About the Webinar
The new opportunity in beauty and cosmetics culture wasn't launched on a runway, developed in a formulation lab, or driven by a viral trend. It arrived quietly in the form of a hormone, a weekly injection, and a body undergoing rapid transformation.GLP-1 receptor agonists like Ozempic and Wegovy were designed to manage blood sugar and reduce weight, but their impact has rippled far beyond these benefits. Besides reshaping food habits, they are driving a cascade of physical changes, including rapid skin changes, skin laxity, hair thinning, and heightened scent sensitivity. They are fundamentally altering how millions of people relate to their bodies and their beauty routines.This webinar brings together perspectives from across the beauty and cosmetics ecosystem, including skincare brands, color cosmetics, aesthetic clinics, ingredient suppliers, fragrance houses, and investors, to examine where disruption is occurring now and how leading companies are rethinking product portfolios, reformulation strategies, and innovation pipelines to stay ahead in a GLP-1 world.
Webinar Agenda
- Portfolio strategies for a GLP-1 world: With 1 out of 8 US adults on GLP-1 drugs and adoption accelerating globally, which effects should be targeted, and what products can be built for this new consumer reality?
- Addressing the unmet need: With 82% of GLP-1 users concerned about loose skin and firmness, and users reporting unexpected changes across the body, which beauty formats and zone-specific solutions are best positioned to meet these needs?
- Smart reformulation vs. trend-chasing: Although the first wave of product launches appeared in 2025-26, the market already offers products relevant to GLP-1 users. Will future activity likely focus on reformulating and repositioning existing formulas, or on developing new ones?
- Move beyond just physical recovery: Is physical recovery the only way to support emotional adjustment and self-connection, or will moving beyond it resonate more strongly with this audience?
- The 12-18 month decision window: Leaders who act now could gain an early-mover advantage in a market that is reshaping billions of dollars in annual spending and make decisions to avoid long-term losses and risks to brand relevance.
Meet the Speakers
Ashu Verma brings over 12 years of experience in the Consumer Packaged Goods industry to his role as an accomplished business leader at Stellarix, where he oversees this segment. He works closely with global clients to accelerate innovation, strengthen operations, and shape future-ready strategies. Proficient in market intelligence, trend scouting, and comprehensive innovation consulting, he provides valuable guidance on sustainable growth, product development, and emerging technologies. Trusted by Fortune 500 firms and rapidly growing startups, he is known for transforming complex market data into clear, actionable insights that deliver measurable results.
Sayan Mondal is an IP, technology, and business consulting professional with 5+ years of experience delivering innovation and strategic intelligence across the beauty and personal care, cosmetics, pharmaceuticals, household care, fragrance and perfumery, and specialty chemicals sectors. Drawing on a strong foundation in chemistry and pharmaceutical sciences, Sayan specializes in translating complex scientific, technical, and market insights into actionable recommendations that support R&D, innovation, new product development (NPD), and strategic business decision-making for global stakeholders.